share_log
Breakings ·  Jul 8 18:30
Kineta Announces Exclusivity and Right of First Offer Agreement for Its Vista Blocking Antibody With Tuhura Biosciences
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment